Intelligence / Healthtech / Health Funding Register
FundingLIVEUpdated 30 Sept 2026
Health Funding Register
Every new private funding round filed with the SEC by US health, biotech and pharma companies.
Sources: SEC Form D · Rebuilt weekly · New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC.
Companies
392
in Q3 2026
Added in 30 days
137
to 30 Sept 2026
Top state
California
66 · 17% of the list
Raised in total
$4.0B
as reported to the SEC
Snapshot · 30 Sept 2026
Explore all 392 Growth
By month
392
Signals
What the register says this week, and why it matters if you sell into it.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
- California leads with 66 raises, followed by Massachusetts (39).
- Companies buy in the months after they raise: new hires, new vendors, new markets.
FiledCompanyLocationIndustryRaised
10 Sept 2026Can-Fite BioPharma Ltd.Ramat Gan, L3Ramat Gan, L3Pharmaceuticals$8.3M10 Sept 2026Polyrizon Ltd.Raanana, L3Raanana, L3Biotechnology$4.0M9 Sept 2026BioLineRx Ltd.Modi'In, L3Modi'In, L3Biotechnology$3.8M4 Sept 2026Pluri Inc.Haifa, L3Haifa, L3Biotechnology$3.7M21 Aug 2026NurExone Biologic Inc.Technion City, Haifa, L3Technion City, Haifa, L3Biotechnology$450K19 Aug 2026Intercure Ltd.Hertzliya, L3Hertzliya, L3Pharmaceuticals–12 Aug 2026Entera Bio Ltd.Jerusalem, L3Jerusalem, L3Biotechnology$275M20 Jul 2026CollPlant Biotechnologies LtdRehovot, L3Rehovot, L3Other Health Care$10.4M7 Jul 2026Pulsenmore Ltd.Omer, L3Omer, L3Other Health Care$7.5M// How AOS uses this